YAP1 acts as a negative regulator of pro-tumor TAZ expression in esophageal squamous cell carcinoma.
Saved in:
| Title: | YAP1 acts as a negative regulator of pro-tumor TAZ expression in esophageal squamous cell carcinoma. |
|---|---|
| Authors: | Kuo YZ; Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, 70101, Taiwan, Republic of China., Kang YR; Institutes of Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan, 70101, Taiwan, Republic of China., Chang WL; Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, 70428, Taiwan, Republic of China., Sim LC; Institutes of Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan, 70101, Taiwan, Republic of China., Hsieh TC; Institutes of Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan, 70101, Taiwan, Republic of China., Chang CH; Institutes of Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan, 70101, Taiwan, Republic of China., Wang YC; Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, 70101, Taiwan, Republic of China., Tsai CJ; Institutes of Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan, 70101, Taiwan, Republic of China., Huang LC; Institutes of Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan, 70101, Taiwan, Republic of China., Tsai ST; Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, 70101, Taiwan, Republic of China. T602511@mail.ncku.edu.tw., Wu LW; Institutes of Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan, 70101, Taiwan, Republic of China. liwhawu@mail.ncku.edu.tw.; Department of Laboratory Science and Technology, College of Health Sciences, Kaohsiung Medical University, Kaohsiung, Taiwan, Republic of China. liwhawu@mail.ncku.edu.tw. |
| Source: | Cellular oncology (Dordrecht, Netherlands) [Cell Oncol (Dordr)] 2022 Oct; Vol. 45 (5), pp. 893-909. Date of Electronic Publication: 2022 Aug 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: Netherlands NLM ID: 101552938 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-3436 (Electronic) Linking ISSN: 22113428 NLM ISO Abbreviation: Cell Oncol (Dordr) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2211-3436 |
|---|---|
| DOI: | 10.1007/s13402-022-00695-4 |
